In a Phase 2 clinical trial , adults with overweight or obesity taking the lowest dose (1 mg) lost about 8.7% of their body weight on average after 48 weeks
Pathway enrichment and network analyses further indicated alterations in amino acid metabolism, glutathione metabolism, and polyamine-related pathways following intervention
MOTS-c's AMPK activation aligns with the body's metabolic circadian rhythm, which peaks in the morning and early afternoon
In general, these undesirable effects occur at the beginning of therapy with growth hormones and also depend on the dose
Intracellular glutathione levels decline with age, chronic inflammation, and certain genetic variations affecting glutathione synthesis or recycling
Log in to your Klarna account to see your estimated purchase power under your profile, or check it in the app any time